Replay Simulations with Personalized Metabolic Model for Treatment Design and Evaluation in Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Background: The capacity to replay data collected in real life by people with type 1 diabetes mellitus (T1DM) would lead to individualized (vs population) assessment of treatment strategies to control blood glucose and possibly true personalization. Patek et al introduced such a technique, relying on regularized deconvolution of a population glucose homeostasis model to estimate a residual additive signal and reproduce the experimental data; therefore, allowing the subject-specific replay of what-if scenarios by altering the model inputs (eg, insulin). This early method was shown to have a limited domain of validity. We propose and test in silico a similar approach and extend the method applicability. Methods: A subject-specific model personalization of insulin sensitivity and meal-absorption parameters is performed. The University of Virginia (UVa)/Padova T1DM simulator is used to generate experimental scenarios and test the ability of the methodology to accurately reproduce changes in glucose concentration to alteration in meal and insulin inputs. Method performance is assessed by comparing true (UVa/Padova simulator) and replayed glucose traces, using the mean absolute relative difference (MARD) and the Clarke error grid analysis (CEGA). Results: Model personalization led to a 9.08 and 6.07 decrease in MARD over a prior published method of replaying altered insulin scenarios for basal and bolus changes, respectively. Replay simulations achieved high accuracy, with MARD <10% and more than 95% of readings falling in the CEGA A-B zones for a wide range of interventions. Conclusions: In silico studies demonstrate that the proposed method for replay simulation is numerically and clinically valid over broad changes in scenario inputs, indicating possible use in treatment optimization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and replay simulation and insulin sensitivity assessment techniques were developed.79,80”
From Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility (2023) · cites this paper as [79]
Citations
Cites
Evaluating clinical accuracy of systems for self-monitoring of blood glucose
Clarke, W. L., Cox, D., Gonder-Frederick, L. A., Carter, W., & Pohl, S. L. (1987) · Diabetes Care · doi:10.2337/diacare.10.5.622 · Cited by 1,435
Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes
Hovorka, R., Canonico, V., Chassin, L. J., Haueter, U., Massi-Benedetti, M., Federici, M. O., Pieber, T. R., Schaller, H. C., Schaupp, L., Vering, T., et al. (2004) · Physiological Measurement · doi:10.1088/0967-3334/25/4/010 · Cited by 1,274
Meal Simulation Model of the Glucose-Insulin System
Dalla Man, C., Rizza, R. A., & Cobelli, C. (2007) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2007.893506 · Cited by 955
The UVA/PADOVA Type 1 Diabetes Simulator: New Features
Man, C. D., Micheletto, F., Lv, D., Breton, M., Kovatchev, B., & Cobelli, C. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296813514502 · Cited by 791 · cited 8×
“1330 Journal of Diabetes Science and Technology 15(6)”
BackgroundMethodInfluentialSelf-citationIn Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes
Kovatchev, B. P., Breton, M., Dalla Man, C., & Cobelli, C. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300106 · Cited by 760
Self-citationDiabetes: Models, Signals, and Control
Cobelli, C., Dalla Man, C., Sparacino, G., Magni, L., De Nicolao, G., & Kovatchev, B. P. (2009) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2009.2036073 · Cited by 511
DAISY: A new software tool to test global identifiability of biological and physiological systems
Bellu, G., Saccomani, M. P., Audoly, S., & D’Angiò, L. (2007) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2007.07.002 · Cited by 452
The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day
Visentin, R., Campos-Náñez, E., Schiavon, M., Lv, D., Vettoretti, M., Breton, M., Kovatchev, B. P., Dalla Man, C., & Cobelli, C. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818757747 · Cited by 280 · cited 1×
“ I t k I t k I t sc c sc c sc 2 1 2 12 2 ( ) = ( ) − ( ) (7)”
Self-citationSimulation Environment to Evaluate Closed-Loop Insulin Delivery Systems in Type 1 Diabetes
Wilinska, M. E., Chassin, L. J., Acerini, C. L., Allen, J. M., Dunger, D. B., & Hovorka, R. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400117 · Cited by 244 · cited 1×
“R t k f Q t k f Q t a q q ( ) = ⋅ ⋅ ( ) + ⋅ ⋅ ( ) 1 1 1 2 (5)”
The oral glucose minimal model: Estimation of insulin sensitivity from a meal test
Della Man, C., Caumo, A., & Cobelli, C. (2002) · IEEE Transactions on Biomedical Engineering · doi:10.1109/10.995680 · Cited by 241
Research works printed but not linked: 1
- Sorenson JT., 1985, A Physiological Model of Glucose Metabolism in Man and Its Use to Design and Assess Improved Insulin Therapies for Diabetes
Cited by
Cappon, G., Vettoretti, M., Sparacino, G., Favero, S. D., & Facchinetti, A. (2023) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2023.3286856 · Cited by 71
Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility
Cobelli, C., & Kovatchev, B. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231195081 · Cited by 46
Digital Twins in Type 1 Diabetes: A Systematic Review
Cappon, G., & Facchinetti, A. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241262112 · Cited by 44
Deichmann, J., Bachmann, S., Burckhardt, M., Pfister, M., Szinnai, G., & Kaltenbach, H. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010289 · Cited by 25
Fathi, A. E., Fabris, C., & Breton, M. D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.795895 · Cited by 19
Self-citation
Metadata
- Authors
- Hughes, J., Gautier, T., Colmegna, P., Fabris, C., & Breton, M. D.
- Affiliations
- University of Virginia (US)
- Corresponding author
- Breton, Marc D
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2020-11-20
- Volume
- 15
- Issue
- 6
- Pages
- 1326-1336
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC8655285
- OpenAlex
- W3103205051
- Cited by
- 34
- References
- 19
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 4 · 2023: 7 · 2022: 1 · 2021: 4
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- PriMed project, UVA Strategic Investment Fund
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 1 diabetes, insulin sensitivity, UVA/Padova simulator, glycemic control, treatment optimization, Clarke error grid, in silico modeling
- MeSH terms
- Algorithms, Blood Glucose, Computer Simulation, Diabetes Mellitus, Type 1, Humans, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Replay Simulations with Personalized Metabolic Model for Treatment Design and Evaluation in Type 1 Diabetes. https://app.cochat.ai/papers/10.1177/1932296820973193
- The paper
- Hughes, J., Gautier, T., Colmegna, P., Fabris, C., & Breton, M. D. (2021). Replay Simulations with Personalized Metabolic Model for Treatment Design and Evaluation in Type 1 Diabetes. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296820973193
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.